[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Clearpoint Neuro Inc (CLPT)

Clearpoint Neuro Inc (CLPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Clearpoint Neuro Inc 120 S. SIERRA AVE. SUITE 100 SOLANA BEACH CA 92075 USA

www.clearpointneuro.com Employees: 172 P: 888-287-9109

Sector:

Medical

Description:

ClearPoint Neuro Inc. provides neurosurgery platform which includes hardware, software, clinical case and market development services for gene therapy cases principally in the United States and Europe. ClearPoint Neuro Inc., formerly known as MRI Interventions Inc., is based in Irvine, California.

Key Statistics

Overview:

Market Capitalization, $K 350,237
Enterprise Value, $K 353,397
Shares Outstanding, K 29,986
Float, K 27,905
% Float 93.06%
Short Interest, K 4,654
Short Float 15.52%
Days to Cover 8.44
Short Volume Ratio 0.60
% of Insider Shareholders 6.94%
% of Institutional Shareholders 30.08%

Financials:

Annual Sales, $ 36,970 K
Annual Net Income, $ -25,540 K
Last Quarter Sales, $ 10,410 K
Last Quarter Net Income, $ -7,790 K
EBIT, $ -24,170 K
EBITDA, $ -21,850 K

Growth:

1-Year Return -18.18%
3-Year Return 30.50%
5-Year Return -35.40%
5-Year Revenue Growth 188.15%
5-Year Earnings Growth -109.30%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.27 on 03/17/26
Next Earnings Date 05/13/26 [AMC]
Earnings Per Share ttm -0.91
EPS Growth vs. Prev Qtr -28.57%
EPS Growth vs. Prev Year -35.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-40 on 07/27/16

CLPT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -122.17%
Return-on-Assets % -40.69%
Profit Margin % -69.08%
Debt/Equity 1.75
Price/Sales 9.30
Price/Cash Flow N/A
Price/Book 11.64
Book Value/Share 0.99
Interest Coverage -9.67
60-Month Beta 1.29
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.